Where Industry Meet Trends

ai robot image

The Public Health Agency of Canada (PHAC) has entered into a five-year contract with Bavarian Nordic for the purchase of its smallpox vaccine ‘Imvamune’ for $56m. Imvamune, with the brand name of Jynneos in the US, and Imvanex in Europe, is approved for the treatment of monkeypox and smallpox vaccine in Canada and the US. In the rest of the world, Imvamune is used only against monkeypox. Bavarian Nordic will not be making deliveries before 2023, as per the contract.

Read More from Biopharma Reporter

Leave a Reply

Your email address will not be published. Required fields are marked *

Welcome to Industry Trends, your go-to platform for insights and updates on the transformative power of AI and Automation across major industries. Our blog focuses on exploring the latest advancements, disruptions, and innovations shaping the future of Retail, Consumer Goods, Finance, Healthcare, and Manufacturing.

At Industry Trends, we are committed to delivering in-depth analysis, thought-provoking articles, and actionable strategies to help businesses and professionals stay ahead in today’s rapidly evolving digital landscape. Whether it’s the rise of intelligent automation in manufacturing, AI-driven personalization in retail, revolutionary changes in consumer goods, or the latest breakthroughs in healthcare and finance, we bring you the stories that matter the most.

Join us as we delve into the future of these industries and uncover how cutting-edge technology is redefining the way we work, live, and interact. Stay informed, stay inspired, and stay prepared with Industry Trends—where industries meet the power of innovation.

en_USEnglish
en_USEnglish